CJC-1295 No DAC and Ipamorelin: Research Stack Considerations

For a wholesale buyer, the considerations that matter here are procurement considerations, not protocol ones. CJC-1295 no DAC and ipamorelin are two distinct research-use-only compounds that appear together constantly in growth-hormone-axis literature because they act on different receptors, and the decision to carry both comes down to four questions: whether each lot's identity and purity are documented by a laboratory you can independently check, whether the "no DAC" designation matches what is actually in the vial, whether your supplier's pricing and minimums are visible before you commit, and whether your counsel is comfortable with your business holding and reselling research material. Neither compound is an approved drug. Nothing below describes human or animal administration, and nothing below is legal advice.

Why these two compounds keep appearing together

The pairing is not marketing. It reflects how the growth hormone axis is studied. CJC-1295 without DAC is a synthetic analog of the first 29 amino acids of growth hormone releasing hormone, with substitutions intended to slow enzymatic degradation of the native fragment. Ipamorelin is a pentapeptide studied as a selective agonist at the growth hormone secretagogue receptor — the ghrelin receptor — a separate signalling route entirely.

Because the two act on different receptor families, research literature has long examined them as complementary tools rather than redundant ones. Studies indicate that secretagogue-receptor agonists and GHRH analogs can produce different signalling patterns when examined separately, which is precisely why investigators co-study them. Research on ipamorelin in particular has focused on its selectivity profile relative to earlier secretagogues.

For a buyer, the practical takeaway is narrow: the two are frequently ordered together, so your catalog planning, your minimum order thinking, and your lot documentation should treat them as a linked pair. If you stock one and not the other, expect the question. If you stock both, expect customers to compare COAs across them and notice inconsistencies in how your supplier documents each.

What you should never do is describe the pairing in outcome terms. These are research compounds. Your product pages, your sales conversations, and your internal training should stay on compound science and documentation, not on effects.

What the absence of a DAC actually changes

DAC stands for Drug Affinity Complex — a moiety designed to bind circulating albumin and substantially extend how long the peptide remains in circulation. The "no DAC" version omits it. This is not a quality tier, a purity grade, or a lower-cost variant of the same molecule. It is a structurally different compound with a materially different pharmacokinetic profile in published research, and the two are not interchangeable in a study design or in your inventory system.

This matters commercially more than most buyers expect. Mislabeling between the two forms is one of the more common documentation failures in this category, and it is difficult for a downstream customer to detect without mass spectrometry data confirming molecular weight. A COA that states purity but never confirms identity does not tell you which of the two you received. That is why identity testing, not just purity testing, belongs on every batch document you accept.

It also means your SKU discipline has to be tighter than for single-form compounds. Separate product listings, separate lot tracking, and COA files that name the exact form in the document itself — not just in the filename — prevent the kind of mix-up that costs a wholesale account.

Comparing the two compounds side by side

Use this as a procurement checklist, not a description of activity. Every row is something you can verify from paperwork before a vial reaches your shelf.

The documentation that should exist before a single vial ships

The single most useful discipline a wholesale buyer can build is refusing to accept a certificate of analysis that does not correspond to the lot number printed on the vial you received. Generic COAs — one document covering every batch of a compound indefinitely — are common in this industry and tell you nothing about the material in your hand.

A batch document worth relying on should let you confirm several things independently:

Identity. Mass spectrometry confirming the expected molecular weight. For CJC-1295 no DAC, this is the only practical way to distinguish it from the DAC-modified form.

Purity. HPLC chromatograms, not just a stated percentage. The trace shows you peak shape and impurity distribution; a number alone can be typed by anyone.

Net peptide content. Purity and peptide content are different measurements. A lyophilized vial contains counterions, residual water, and excipients alongside the peptide itself. Purity describes the fraction of peptide material that is the target sequence; peptide content describes how much peptide is in the vial at all. Suppliers who report only the first are reporting the more flattering figure.

Contamination panels. Bacterial endotoxin, bioburden or sterility as applicable, heavy metals, residual solvents from synthesis, and water content. Each of these is a separate assay with a separate cost, which is exactly why they are the first items quietly dropped from a cheap supply chain.

Traceability. Lot number, manufacture date, and the testing laboratory named on the document. If you cannot tell who ran the assay, you cannot follow up on it.

Ask how COAs are delivered, too. Some suppliers treat lab documentation as a paid add-on or release it only after purchase. Publicly posted, lot-matched COAs that a buyer can check before ordering are a meaningfully different standard from documentation supplied on request.

Supplier mechanics: pricing, minimums, and fulfillment

Wholesale pricing in this category generally works on volume tiers, sometimes combined with category or catalog-breadth commitments. Margins and minimums vary widely by supplier, compound, and order size, and any source quoting you a universal figure is guessing. What you can and should establish before applying anywhere is the structure itself:

• Is the tier schedule published, or disclosed only after a sales call?
• Are minimums set per SKU, per order, or per account period?
• Do prices change between quote and invoice?
• Who holds inventory, and are orders fulfilled domestically or drop-shipped from overseas?
• What is the documented process when a lot arrives short, damaged, or with a COA mismatch?

That last question separates real programs from order-taking. A supplier without a written non-conformance process has not thought about what happens on a bad day, and a bad day is when you find out what your supplier actually is.

Fulfillment origin drives everything downstream — lead time, customs exposure, and how quickly you can recover from a stockout on a fast-moving pair like this one. Domestic fulfillment shortens the loop and removes a category of border risk that is difficult to price in advance.

Licensing and compliance questions you need to resolve yourself

This section is informational and is not legal advice. Whether your specific business may purchase, hold, label, and resell research-use-only compounds is not a question anyone selling you those compounds should answer for you.

The questions worth putting in front of your attorney generally include: how research-use-only material must be labeled and stored in your operation; whether your business structure or professional license affects what you may purchase or resell; what recordkeeping you are expected to maintain; how your marketing language is likely to be read by regulators; and what your obligations are if a supplier issues a recall or correction notice. State-level requirements differ, and your state board may take positions that your counsel needs to read directly rather than summarized.

Talk to your veterinarian, medical director, pharmacist, or whichever licensed professional is on record for your operation — and to your attorney — before you assume a research compound fits your business model. Also examine your marketing, not just your paperwork. Compliance failures in this space more often start with a product description than with a purchase order.

What Real Peptides does differently

Real Peptides supplies research compounds tested to 99%+ HPLC purity, with a 7-panel testing regime applied at the batch level rather than a single historical sample. Certificates of analysis are publicly verifiable — a prospective partner can pull the lab results for a lot and read them before deciding whether to open an account, rather than requesting documentation after committing to an order or paying separately for it.

Orders are fulfilled from within the United States, with shipping in 5–7 days. Onboarding into the Wholesale Partner Program runs as a 3-step application rather than an open-ended negotiation, so a buyer can find out where they stand without a drawn-out sales process.

Both compounds discussed here are stocked, and both are documented the same way: the CJC-1295 No DAC 10mg and Ipamorelin 10mg listings carry the same batch-level testing standard as the rest of the catalog. All compounds are research use only and are not sold for human consumption.

If you are evaluating suppliers, the fairest test is a direct one: pull a lot-matched COA from Real Peptides, pull whatever your current supplier will give you, and compare what each document actually proves. That comparison usually settles the question faster than a sales conversation.

Buyers who already know what they need to stock and want pricing tiers and minimums in writing can start the Wholesale Partner Program application; the qualification step is short, and the answer comes back either way.

Buyers building out an adjacent range often review the Growth Factor & Tissue Signaling Research and Performance & Recovery Research collections alongside these two, and compounds such as Tesamorelin 10mg and BPC-157 10mg are documented to the same standard across the full catalog at realpeptides.co.